Health

Results: 8977-8988 of 9418

First Patient Dosed for MRCT Phase 3 Study on First-Line LS-SCLC of Henlius Anti-PD-1 mAb Serplulimab in Europe

PR Newswire associated0

Cumulus Neuroscience Presents Data at CTAD 2023 Annual Meeting

LivaNova to Present at the Stifel and Wolfe Healthcare Conferences

PR Newswire associated0

FDA Meeting Feedback Puts Turn Biotechnologies on Track to be First Longevity Company Taking Cell Rejuvenation Therapy to Clinic

PR Newswire associated0

NEWLY-LAUNCHED AMAZFIT ACTIVE AND AMAZFIT ACTIVE EDGE INTRODUCE A STYLISH WAY TO STAY ACTIVE & STAY HEALTHY

PR Newswire associated0

ESAOTE's new S-scan Open redefines excellence in magnetic resonance imaging

Velocity aggressively expands MASH/MASLD capabilities with latest site acquisitions

PR Newswire associated0

Alkermes plc Reports Third Quarter 2023 Financial Results

RQM+™ Appoints Eric Pauls as Chief Customer Officer

Everdrone introduces game-changing multipurpose E2 drone to revolutionize emergency response

EnginZyme Produces Key mRNA Vaccine Ingredient Using Biocatalysis

First patient treated in the second dose group in Annexin's RVO study